连续性肾脏替代治疗肝素全身抗凝期间不同采血部位对凝血的影响

Influence of different blood collection sites on coagulation during systemic heparin anticoagulation period treated by continuous renal replacement therapy

  • 摘要:
    目的 探究行肝素全身抗凝的连续肾脏替代治疗(CRRT)时在不同部位采血对凝血结果的影响。
    方法 选取行CRRT且采用肝素全身抗凝的患者78例,采用自身对照法,于CRRT体外循环管路输入端采样口、动脉测压导管采血点以及患者外周静脉同时采取血标本,送检凝血四项,比较采血部位凝血结果的差异。
    结果 以肝素全身抗凝方式实施CRRT时,在CRRT体外循环管路输入端采样口、患者的动脉测压管及外周静脉抽取血样标本监测凝血四项指标,差异均无统计学意义(P>0.05), 不同血滤机亚组分析,不同肝素剂量亚组分析,结果差异均无统计学意义(P>0.05)。
    结论 在CRRT治疗过程中,经管路输入端采样口采血、动脉测压管采血可替代外周静脉采血,对凝血结果无影响。

     

    Abstract:
    Objective To investigate the impact of blood sampling from different sites on coagulation results during systemic heparin anticoagulation period treated by continuous renal replacement therapy (CRRT).
    Methods Seventy-eight patients undergoing CRRT with systemic heparin anticoagulation were selected. Using a self-control method, blood samples were simultaneously collected from sampling port at input end of the CRRT extracorporeal circuit, the arterial pressure monitoring catheter, and the peripheral vein of the patients. The four coagulation parameters were tested, and the differences in coagulation results among the blood sampling sites were compared.
    Results During CRRT with systemic heparin anticoagulation, the four coagulation parameters using blood samples collected from the sampling port at the input end of the CRRT extracorporeal circuit, the arterial pressure monitoring catheter, and the peripheral vein showed no statistically significant differences (P>0.05). Subgroup analyses based on different hemofiltration machines and heparin doses also showed no statistically significant differences (P>0.05).
    Conclusion During CRRT, blood sampling from the sampling port at the input end of the circuit or the arterial pressure monitoring catheter can be used as an alternative to peripheral venous blood sampling, with no impact on coagulation results.

     

/

返回文章
返回